APA (7th ed.) Citation

J, W., D, H., JK, S., Ł, M., K, D., & I, G. (2025). Serum hsa-miR-22-3p, hsa-miR-885-5p, Lipase-to-Amylase Ratio, C-Reactive Protein, CA19-9, and Neutrophil-to-Lymphocyte Ratio as Prognostic Factors in Advanced Pancreatic Ductal Adenocarcinoma. Current issues in molecular biology, 47(1), . https://doi.org/10.3390/cimb47010027

Chicago Style (17th ed.) Citation

J, Wnuk, Hudy D, Strzelczyk JK, Michalecki Ł, Dybek K, and Gisterek-Grocholska I. "Serum Hsa-miR-22-3p, Hsa-miR-885-5p, Lipase-to-Amylase Ratio, C-Reactive Protein, CA19-9, and Neutrophil-to-Lymphocyte Ratio as Prognostic Factors in Advanced Pancreatic Ductal Adenocarcinoma." Current Issues in Molecular Biology 47, no. 1 (2025). https://doi.org/10.3390/cimb47010027.

MLA (9th ed.) Citation

J, Wnuk, et al. "Serum Hsa-miR-22-3p, Hsa-miR-885-5p, Lipase-to-Amylase Ratio, C-Reactive Protein, CA19-9, and Neutrophil-to-Lymphocyte Ratio as Prognostic Factors in Advanced Pancreatic Ductal Adenocarcinoma." Current Issues in Molecular Biology, vol. 47, no. 1, 2025, https://doi.org/10.3390/cimb47010027.